William Blair & Company’s Intersect ENT, Inc XENT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-29,564
Closed -$505K 1973
2021
Q2
$505K Buy
29,564
+100
+0.3% +$1.87K ﹤0.01% 1142
2021
Q1
$615K Sell
29,464
-564
-2% -$13K ﹤0.01% 1057
2020
Q4
$688K Sell
30,028
-4,717
-14% -$89.8K ﹤0.01% 989
2020
Q3
$567K Sell
34,745
-575
-2% -$10.4K ﹤0.01% 934
2020
Q2
$478K Sell
35,320
-19,550
-36% -$227K ﹤0.01% 954
2020
Q1
$650K Sell
54,870
-6,719
-11% -$149K ﹤0.01% 798
2019
Q4
$1.53M Sell
61,589
-411
-0.7% -$8.33K 0.01% 668
2019
Q3
$1.05M Buy
62,000
+52,547
+556% +$956K 0.01% 733
2019
Q2
$215K Sell
9,453
-1,640
-15% -$44.2K ﹤0.01% 1284
2019
Q1
$357K Sell
11,093
-50
-0.4% -$1.55K ﹤0.01% 1084
2018
Q4
$314K Sell
11,143
-6,500
-37% -$190K ﹤0.01% 1073
2018
Q3
$507K Sell
17,643
-225
-1% -$6.76K ﹤0.01% 953
2018
Q2
$669K Sell
17,868
-1,710
-9% -$67.1K ﹤0.01% 847
2018
Q1
$769K Buy
19,578
+8,253
+73% +$301K 0.01% 778
2017
Q4
$367K Sell
11,325
-1,500
-12% -$45K ﹤0.01% 1064
2017
Q3
$399K Sell
12,825
-7,475
-37% -$221K ﹤0.01% 1009
2017
Q2
$567K Sell
20,300
-19,600
-49% -$444K ﹤0.01% 938
2017
Q1
$543K Buy
39,900
+9,756
+32% +$137K ﹤0.01% 877
2016
Q4
$365K Sell
30,144
-24,585
-45% -$318K ﹤0.01% 934
2016
Q3
$867K Sell
54,729
-18,153
-25% -$273K 0.01% 684
2016
Q2
$942K Sell
72,882
-22,417
-24% -$351K 0.01% 649
2016
Q1
$1.81M Sell
95,299
-43,000
-31% -$779K 0.02% 478
2015
Q4
$3.11M Sell
138,299
-461
-0.3% -$9.11K 0.03% 374
2015
Q3
$3.25M Buy
138,760
+42,435
+44% +$1.17M 0.03% 407
2015
Q2
$2.76M Buy
+96,325
New +$2.52M ﹤0.01% 1240

Other funds holding XENT

William Blair & Company's XENT Position: Q3 2021 in Review

William Blair & Company sold out of Intersect ENT, Inc (XENT) in Q3 2021, closing a stake of 29,564 shares — an estimated $505K sold.

William Blair & Company first reported a position in XENT in Q2 2015 and held it in 25 quarters. The position peaked at $3.25M in Q3 2015. 123 funds tracked by Wall St. Rank hold XENT as of Q3 2021.

  • William Blair & Company reported no remaining Intersect ENT, Inc position as of Q3 2021 after selling out during the quarter.
  • William Blair & Company sold 29,564 Intersect ENT, Inc shares in Q3 2021, an estimated $505K.
  • William Blair & Company first reported a position in Intersect ENT, Inc in Q2 2015 and held it in 25 quarters.
  • William Blair & Company's Intersect ENT, Inc position peaked at $3.25M in Q3 2015.
  • 123 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q3 2021.

Based on William Blair & Company's 13F filing for Q3 2021, filed 12 Nov 2021.